Top Page
Venture Life
(LSE:VLG)
Venture Life (VLG) vs. iShares MSCI United Kingdom ETF (EWC)
Venture Life Business Overview & Revenue Model
Venture Life Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.53M | 26.59M | 51.41M | 43.98M | 32.76M | 30.08M |
| Gross Profit | 9.88M | 12.19M | 20.15M | 17.66M | 12.96M | 12.85M |
| EBITDA | 11.40M | 4.32M | 9.95M | 7.61M | 5.16M | 5.60M |
| Net Income | -88.00K | -314.00K | 921.00K | 520.00K | 2.40M | 2.37M |
Balance Sheet | ||||||
| Total Assets | 124.91M | 124.49M | 119.50M | 125.29M | 103.63M | 92.68M |
| Cash, Cash Equivalents and Short-Term Investments | 2.01M | 3.05M | 5.62M | 5.63M | 5.24M | 42.09M |
| Total Debt | 23.28M | 23.86M | 24.39M | 26.85M | 12.73M | 11.18M |
| Total Liabilities | 49.68M | 49.08M | 43.24M | 49.63M | 30.47M | 20.57M |
| Stockholders Equity | 75.23M | 75.41M | 76.25M | 75.66M | 73.16M | 72.11M |
Cash Flow | ||||||
| Free Cash Flow | 1.41M | 8.34M | 5.81M | 1.36M | -2.66M | 637.00K |
| Operating Cash Flow | 1.44M | 8.35M | 8.22M | 5.57M | 601.00K | 2.71M |
| Investing Cash Flow | -875.00K | -11.29M | -5.34M | -11.69M | -39.18M | -7.53M |
| Financing Cash Flow | -337.00K | 1.78M | -2.81M | 6.92M | 1.50M | 36.27M |
Venture Life Technical Analysis
Venture Life Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £33.74B | 22.54 | 9.35% | 1.51% | -2.12% | 42.10% | |
65 Neutral | £82.75M | ― | ― | ― | ― | ― | |
63 Neutral | £114.81M | -5.78 | -396.71% | ― | 93.48% | 51.18% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £730.83M | -14.17 | ― | ― | -0.28% | 22.94% | |
53 Neutral | £25.80M | -36.67 | -51.21% | ― | 61.13% | 33.33% | |
42 Neutral | £3.95M | -1.98 | -73.08% | ― | ― | ― |
Venture Life Corporate Events
Venture Life Group PLC has issued 48,000 new ordinary shares following the exercise of share options by a number of employees, with admission of these shares to trading on AIM expected to take effect on 5 February 2026. After the admission, the company’s total shares in issue will rise to 128,860,145, of which 4,372,800 are held in treasury, resulting in 124,487,345 voting rights, a key reference figure for shareholders monitoring and reporting their holdings under UK disclosure rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £69.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued to execute its share buyback programme, repurchasing 200,000 ordinary shares at a volume-weighted average price of 67 pence per share through Cavendish Capital Markets, with the acquired stock to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 4,372,800 are held in treasury, leaving 124,439,345 voting rights in circulation, a figure that shareholders can use to assess and report any changes in their notifiable holdings under regulatory disclosure rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £69.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group plc has repurchased 200,000 ordinary shares at a volume-weighted average price of 67 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 4,372,800 are held in treasury, leaving 124,439,345 voting rights in circulation, a change that may affect shareholders’ disclosure requirements and signals continued capital management activity by the group.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £69.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 164,604 ordinary shares at a volume-weighted average price of 67.68 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 4,172,800 are held in treasury, leaving 124,639,345 voting rights in circulation, a figure that will guide shareholders’ disclosure obligations and marginally consolidates existing investors’ proportional ownership.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued to execute its previously announced share buyback programme, repurchasing 150,000 ordinary shares at a volume-weighted average price of 67.78 pence through broker Cavendish Capital Markets. The shares will be held in treasury, leaving 128,812,145 ordinary shares in issue, of which 4,008,196 are in treasury, and reducing the effective voting share capital to 124,803,949, a figure the company says shareholders should use when assessing disclosure thresholds under FCA transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £73.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 149,000 of its own ordinary shares at a volume-weighted average price of 66.88 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 3,858,196 are held in treasury, leaving 124,953,949 voting rights in circulation, a change that may affect shareholder notification thresholds and reflects continued use of capital management tools to adjust its share base and potentially enhance shareholder value.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group plc, a UK-headquartered consumer self-care and healthcare products group, has continued its previously announced share buyback programme with the repurchase of 200,000 ordinary shares at a volume-weighted average price of 65.88 pence per share, with the shares to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 3,709,196 are held in treasury, leaving 125,102,949 voting shares outstanding, a change that slightly reduces the free float and may affect existing shareholders’ percentage holdings and related disclosure obligations under the FCA’s transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group reported a strong twelve-month trading performance to 31 December 2025, with revenue from continuing operations rising 32% to £35.1 million, or 11.1% on a proforma basis, driven predominantly by volume growth and robust expansion of its Power Brands portfolio. UK revenues surged 20.7% to £25.7 million following increased advertising and promotion, with standout gains from Balance Activ, Earol, and a 44% proforma jump in the Health & Her/Him brands, while international revenues fell 8.7% due mainly to order timing and temporary distributor disruption that has now been resolved. The group has completed its pivot to a pure branded consumer healthcare model after disposing of its CDMO operations, is consolidating international management into its UK commercial team to build larger, more strategic partnerships, and is investing heavily in new product development in collaboration with Healthea Group alongside a new Microsoft Dynamics 365 ERP system to support a data- and digital-led strategy. Backed by a strong net cash position of £34.4 million, an ongoing share buyback programme, and an active pipeline of earnings-enhancing M&A targets in women’s and men’s health, energy management and hormonal health, the board reiterated confidence in meeting revenue and adjusted EBITDA expectations for the extended 17-month period to 31 May 2026.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 51,828 of its own ordinary shares at a volume-weighted average price of 65.84 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 3,509,196 are held in treasury, leaving 125,302,949 voting rights in circulation, a change relevant for shareholders’ regulatory disclosures and reflecting ongoing capital management by the group.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued its previously announced share buyback programme with the repurchase of 73,427 ordinary shares at a volume-weighted average price of 65.08 pence per share, with the shares to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 3,457,368 are held in treasury, leaving 125,354,777 voting rights outstanding, a change that may affect shareholder disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued to execute its share buyback programme, repurchasing 70,048 ordinary shares at a volume-weighted average price of 65.54 pence per share through Cavendish Capital Markets, with all acquired shares to be held in treasury. Following this latest transaction, the company has 128,812,145 ordinary shares in issue, of which 3,383,941 are held in treasury, leaving 125,428,204 voting rights in circulation, a change that may affect shareholder notification thresholds under UK disclosure rules and underscores the group’s ongoing capital management and shareholder-return strategy.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £64.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has issued 75,000 new ordinary shares following the exercise of employee share options, with admission of these shares to trading on AIM expected to take effect on 23 January 2026. Following admission, the company will have 128,812,145 ordinary shares in issue, of which 3,313,893 are held in treasury, resulting in 125,498,252 voting rights, a figure shareholders can use to assess whether they must disclose changes in their ownership under regulatory transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £73.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 200,000 ordinary shares at a volume-weighted average price of 67.50 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 3,313,893 are held in treasury, leaving 125,423,252 voting rights in circulation, a change that may affect shareholders’ disclosure obligations and marginally enhances remaining investors’ proportional ownership and earnings per share potential.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £68.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 200,000 of its own ordinary shares at a volume-weighted average price of 67.36 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 3,113,893 are held in treasury, leaving 125,623,252 voting rights in circulation, a figure the company says shareholders should use to assess disclosure requirements under UK transparency rules and which marginally consolidates remaining investors’ proportional stakes.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 49,475 of its own ordinary shares at a volume-weighted average price of 66.98 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,913,893 are held in treasury, leaving 125,823,252 voting shares in circulation, a change that may affect shareholder calculations for regulatory disclosure thresholds and slightly consolidates existing investors’ relative stakes.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued to execute its previously announced share buyback programme, repurchasing 36,557 ordinary shares at a volume-weighted average price of 66.98p per share through Cavendish Capital Markets and holding the shares in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,864,418 are held in treasury, leaving 125,872,727 voting rights in circulation, a figure that will be used by shareholders in assessing disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 36,557 ordinary shares at a volume-weighted average price of 66.98 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the group has 128,737,145 ordinary shares in issue, of which 2,864,418 are held in treasury, leaving 125,872,727 voting rights in circulation, a change that may affect shareholder disclosure thresholds and signals continued capital management activity by the consumer healthcare group.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 107,880 ordinary shares at a volume-weighted average price of 66.88 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,827,861 are held in treasury, leaving 125,909,284 voting rights outstanding, a figure shareholders can use to assess disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 200,000 of its own ordinary shares at a volume-weighted average price of 66.85 pence per share under its previously announced share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,719,981 are held in treasury, leaving 126,017,164 voting rights in circulation, a change that will be relevant for investors’ disclosure calculations under FCA transparency rules and underscores the group’s ongoing use of buybacks as a capital management tool.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has disclosed that chief executive Jerry Randall has sold 387,705 ordinary shares at a volume-weighted average price of 66.22 pence per share to cover the exercise price and personal tax liabilities arising from the recent exercise of options over 483,333 shares. Following the disposal, Randall retains a beneficial holding of 2,348,828 ordinary shares, representing about 1.82% of the company’s issued share capital, providing investors with updated visibility on executive ownership levels and aligning the transaction with market abuse regulation disclosure requirements.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 180,000 of its own ordinary shares at a volume-weighted average price of 66.67 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,519,981 are held in treasury, leaving 126,217,164 voting shares outstanding, a change that adjusts the capital structure and provides an updated denominator for shareholders monitoring disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 400,000 of its own ordinary shares at a volume-weighted average price of 66.85 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,737,145 ordinary shares in issue, of which 2,339,981 are held in treasury, leaving 126,397,164 voting rights in circulation, information that will guide shareholders in assessing disclosure thresholds under UK regulatory rules and signals continued capital management activity by the group.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 200,000 of its own ordinary shares at a volume-weighted average price of 66.96p under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction and the recent admission of new shares from option exercises, the company now has 128,737,145 ordinary shares in issue, of which 1,939,981 are held in treasury, leaving 126,797,164 voting rights outstanding, a figure that will guide shareholders in monitoring and disclosing changes to their holdings under UK regulatory rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has confirmed that, as of 31 December 2025, it has 128,253,812 ordinary shares of 0.3 pence in issue, of which 1,739,981 are held in treasury, leaving 126,513,831 shares carrying voting rights. The company noted that this total voting rights figure will serve as the reference point for shareholders in determining whether they must disclose holdings or changes in their interests under the FCA’s Disclosure Guidance and Transparency Rules, providing clarity and transparency over the group’s current capital and governance structure.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has issued 483,333 new ordinary shares following the exercise of share options by chief executive Jerry Randall under the company’s Long-Term Incentive Plan, at an exercise price of 41 pence per share, increasing his beneficial holding to 2,736,533 shares, or about 2.13% of the company’s issued share capital. The new shares are expected to be admitted to trading on AIM on 7 January 2025, taking the total shares in issue to 128,737,145, of which 1,739,981 are held in treasury, and setting the company’s voting rights at 126,997,164, a reference figure for investors monitoring disclosure thresholds under UK market transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 145,780 ordinary shares at a volume-weighted average price of 65.75 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,253,812 ordinary shares in issue, of which 1,739,981 are held in treasury, resulting in 126,513,831 voting rights, a change that may affect shareholders’ disclosure thresholds under UK transparency rules and underscores the group’s continued capital management initiatives.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 30,212 ordinary shares at a volume-weighted average price of 65.44 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,253,812 ordinary shares in issue, of which 1,594,201 are held in treasury, leaving 126,659,611 voting rights in circulation, a figure relevant for investors monitoring their disclosure obligations under UK transparency rules and signalling continued capital management activity by the group.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has continued to execute its previously announced share buyback programme with the market repurchase of 200,000 ordinary shares at a volume-weighted average price of 65.64p, with the shares to be held in treasury. Following this latest transaction, the company’s total shares in issue stand at 128,253,812, of which 1,563,989 are held in treasury, leaving 126,689,823 voting shares outstanding, a figure that will guide investors’ disclosure calculations and marginally enhance earnings per share and capital management flexibility.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 200,000 of its ordinary shares at a volume-weighted average price of 65.90 pence as part of its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction and the recent admission of 201,500 new shares from option exercises, the company will have 128,253,812 ordinary shares in issue, of which 1,363,989 are held in treasury, leaving 126,889,823 voting shares outstanding, a figure shareholders can use to assess disclosure thresholds under FCA transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has repurchased 300,000 of its own ordinary shares at a volume-weighted average price of 65.97 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction and the recent issuance of 201,500 new shares from option exercises, the company now has 128,253,812 ordinary shares in issue, of which 1,163,989 are held in treasury, leaving 127,089,823 voting rights in circulation, a figure investors can use to assess and report changes in their holdings under regulatory disclosure rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group has issued 201,500 new ordinary shares following the exercise of share options by employees, with the shares expected to be admitted to trading on AIM on 24 December 2025. Following this admission, the company will have 128,253,812 ordinary shares in issue, of which 863,989 are held in treasury, resulting in 127,389,823 voting rights, a figure that shareholders can use to assess whether they must disclose changes in their holdings under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback program, purchasing 35,279 ordinary shares at a volume-weighted average price of 61.92 pence per share. These shares will be held as treasury shares, impacting the company’s total voting rights, which now stand at 127,268,304. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 144,721 ordinary shares at a volume-weighted average price of 61.76 pence per share. This transaction is part of their share buyback programme announced earlier, and the acquired shares will be held as treasury shares. Following this repurchase, the total number of voting rights in the company stands at 127,303,583. This move is likely to impact the company’s stock liquidity and may influence shareholder value, reflecting a strategic decision to manage capital and shareholder interests.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback program, acquiring 52,690 ordinary shares at a volume-weighted average price of 61.82 pence per share. These shares will be held as treasury shares, impacting the total number of voting rights in the company, which now stands at 127,448,304. This move is part of the company’s ongoing efforts to manage its capital structure and may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 10,000 ordinary shares at a volume-weighted average price of 61.51 pence per share. This move, part of a previously announced buyback program, results in the company holding 551,318 shares in treasury, with a total of 128,052,312 ordinary shares in issue. The buyback could potentially impact shareholder voting rights and reflects the company’s strategic financial management.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC, a leader in the global consumer healthcare sector, has executed a share buyback program, purchasing 65,000 ordinary shares at a volume-weighted average price of 61.59 pence per share. These shares will be held as treasury shares, and the total number of voting rights in the company will be adjusted accordingly. This move is part of the company’s strategic financial management to optimize shareholder value and may influence stakeholders’ interest calculations under regulatory guidelines.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has completed the sale of its non-core Oral Care Assets, including Ultradex and Dentyl brands, to Covestus Holdings Ltd for up to £4.5 million. This divestment aligns with Venture Life’s strategic focus on its higher margin, higher growth core brands, and the proceeds will be used to bolster its acquisition strategy and drive innovation in its core product categories. The sale also allows the company to streamline operations and focus on its Power Brands, promoting proactive healthy longevity for consumers.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 25,000 ordinary shares at a volume-weighted average price of 61.15 pence per share, as part of its previously announced buyback program. The repurchased shares will be held as treasury shares, affecting the total number of voting rights, which now stands at 127,575,994. This move is part of the company’s strategy to manage its capital structure and may impact shareholder calculations under the FCA’s rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback program, purchasing 75,000 ordinary shares at a volume-weighted average price of 60.50 pence per share. The acquired shares will be held as treasury shares, adjusting the total number of voting rights in the company to 127,600,994. This move is part of the company’s strategy to manage its capital structure and could potentially impact shareholder value and market perception.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC announced its total voting rights as of 30 November 2025, with 127,675,994 ordinary shares carrying voting rights out of a total issued share capital of 128,052,312 shares. This information is crucial for shareholders to determine their interest in the company’s share capital under the FCA’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC, a leader in proactive healthy longevity within the global consumer healthcare sector, has executed a share buyback program, purchasing 75,000 ordinary shares at a volume-weighted average price of 60.57 pence per share. This move, facilitated by Cavendish Capital Markets Limited, results in a total of 128,052,312 ordinary shares in issue, with 376,318 held in treasury, impacting the total number of voting rights and potentially influencing shareholder interest notifications under FCA’s rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 10,000 ordinary shares at a volume-weighted average price of 60.56 pence per share. This action is part of their ongoing share buyback program, and the acquired shares will be held as treasury shares. Following this transaction, the company has 128,052,312 ordinary shares in issue, with 301,318 held in treasury, impacting the total voting rights available to shareholders. This move reflects the company’s strategic financial management and may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback program, purchasing 65,479 ordinary shares at a volume-weighted average price of 58.21 pence per share. These shares will be held as treasury shares, impacting the company’s total voting rights, which now stand at 127,760,994. This strategic move is part of the company’s ongoing efforts to manage its capital structure and may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 20,000 ordinary shares at a price of 59.21 pence each, as part of its ongoing share buyback programme. The acquired shares will be held as treasury shares, adjusting the total number of voting rights in the company to 127,826,473. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback, purchasing 120,000 ordinary shares at a volume-weighted average price of 57.81 pence per share, as part of its share buyback program. This transaction, conducted through Cavendish Capital Markets Limited, results in the company holding these shares as treasury shares, impacting the total number of voting rights available. The move is likely aimed at optimizing the company’s capital structure and potentially increasing shareholder value.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC has executed a share buyback program, purchasing 61,599 ordinary shares at an average price of 58.9025 pence per share. These shares will be held as treasury shares, affecting the total number of voting rights in the company, which now stands at 127,966,473. This move is part of the company’s strategic financial management, potentially impacting shareholder value and market perception.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Venture Life Group PLC, a leader in the global consumer healthcare sector, has executed a share buyback program, acquiring 24,240 ordinary shares at an average price of 59.65 pence each. These shares will be held as treasury shares, affecting the total voting rights in the company, which now stands at 128,028,072. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £57.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.